Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

Anne Zimmerman, editor-in-chief of the Columbia University online journal, <a href=" target="_blank">Voices in Bioethics ...

In a dramatic turn of events that makes for some great storytelling, Cidara's novel drug-Fc conjugate, once locked up in a ...

Longer time horizons and therapeutic area expertise make philanthropy venture capital an attractive option for ...

Ironwood Pharmaceuticals is a smaller company than it was in 2016, when Life Science Leader wrote a feature article about its ...